These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 3817664)
1. Toxic-oil syndrome: case reports associated with the ITH oil refinery in Sevilla. Posada M; Castro M; Kilbourne EM; Diaz de Rojas F; Abaitua I; Tabuenca JM; Vioque A Food Chem Toxicol; 1987 Jan; 25(1):87-90. PubMed ID: 3817664 [TBL] [Abstract][Full Text] [Related]
2. Toxic oil syndrome: traceback of the toxic oil and evidence for a point source epidemic. Posada de la Paz M; Philen RM; Borda IA; Sicilia Socias JM; Gómez de la Cámara A; Kilbourne EM Food Chem Toxicol; 1996 Mar; 34(3):251-7. PubMed ID: 8621106 [TBL] [Abstract][Full Text] [Related]
3. Oil ingestion and the toxic-oil syndrome: results of a survey of residents of the Orcasur neighbourhood in Madrid, Spain. Cañas R; Kilbourne EM Int J Epidemiol; 1987 Mar; 16(1):3-6. PubMed ID: 3570618 [TBL] [Abstract][Full Text] [Related]
4. Possible etiologic agents for toxic oil syndrome: fatty acid esters of 3-(N-phenylamino)-1,2-propanediol. Hill RH; Schurz HH; Posada de la Paz M; Abaitua Borda I; Philen RM; Kilbourne EM; Head SL; Bailey SL; Driskell WJ; Barr JR Arch Environ Contam Toxicol; 1995 Feb; 28(2):259-64. PubMed ID: 7710294 [TBL] [Abstract][Full Text] [Related]
5. Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain. Posada de la Paz M; Philen RM; Abaitua Borda I; Diez Ruiz-Navarro M; Abraira Santos V; Pozo Rodríguez F; Pla Mestre R; Pollán Santamaría M; Sicilia Socias JM; Azpeitia Gamazo P Epidemiology; 1994 Jul; 5(4):404-9. PubMed ID: 7918809 [TBL] [Abstract][Full Text] [Related]
6. Manufacturing processes at two French rapeseed oil companies: possible relationships to toxic oil syndrome in Spain. Posada de la Paz M; Philen RM; Abaitua Borda I; Bernert JT; Gancedo JC; DuClos PJ; Kilbourne EM Food Chem Toxicol; 1991 Dec; 29(12):797-803. PubMed ID: 1765323 [TBL] [Abstract][Full Text] [Related]
7. Late cases of toxic oil syndrome: evidence that the aetiological agent persisted in oil stored for up to one year. Posada de la Paz M; Abaitua Borda I; Kilbourne EM; Tabuenca Oliver JM; Diaz de Rojas F; Castro Garcia M Food Chem Toxicol; 1989 Aug; 27(8):517-21. PubMed ID: 2792975 [TBL] [Abstract][Full Text] [Related]
8. Cytokine mRNA expression in lung tissue from toxic oil syndrome patients: a TH2 immunological mechanism. del Pozo V; de Andrés B; Gallardo S; Cárdaba B; de Arruda-Chaves E; Cortegano MI; Jurado A; Palomino P; Oliva H; Aguilera B; Posada M; Lahoz C Toxicology; 1997 Mar; 118(1):61-70. PubMed ID: 9074654 [TBL] [Abstract][Full Text] [Related]
9. Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain. Kilbourne EM; Bernert JT; Posada de la Paz M; Hill RH; Abaitua Borda I; Kilbourne BW; Zack MM Am J Epidemiol; 1988 Jun; 127(6):1210-27. PubMed ID: 3369420 [TBL] [Abstract][Full Text] [Related]
10. Chemical-induced autoimmune reactions and Spanish toxic oil syndrome. Focus on hydantoins and related compounds. Kammüller ME; Bloksma N; Seinen W J Toxicol Clin Toxicol; 1988; 26(3-4):157-74. PubMed ID: 3047417 [TBL] [Abstract][Full Text] [Related]
11. Spanish toxic oil syndrome: ten years after the disaster. Ortega-Benito JM Public Health; 1992 Jan; 106(1):3-9. PubMed ID: 1603915 [TBL] [Abstract][Full Text] [Related]
12. Toxic oil syndrome: the perspective after 20 years. Posada de la Paz M; Philen RM; Borda AI Epidemiol Rev; 2001; 23(2):231-47. PubMed ID: 12192735 [TBL] [Abstract][Full Text] [Related]
13. Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome. Mayeno AN; Benson LM; Naylor S; Colberg-Beers M; Puchalski JT; Gleich GJ Chem Res Toxicol; 1995; 8(7):911-6. PubMed ID: 8555405 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of the toxic oil syndrome. Philen RM; Posada de la Paz M; Hill RH; Schurz HH; Abaitua Borda I; Gómez de la Cámara A; Kilbourne EM Arch Toxicol Suppl; 1997; 19():41-52. PubMed ID: 9079193 [No Abstract] [Full Text] [Related]
15. The toxic oil syndrome (TOS, 1981): from the disease towards a toxicological understanding of its chemical aetiology and mechanism. Aldridge WN Toxicol Lett; 1992 Dec; 64-65 Spec No():59-70. PubMed ID: 1471212 [TBL] [Abstract][Full Text] [Related]
16. The association of oil ingestion with toxic oil syndrome in two convents. Diaz de Rojas F; Castro García M; Abaitua Borda I; Alonso Gordo JM; Posada de la Paz M; Kilbourne EM; Tabuenca Oliver JM Am J Epidemiol; 1987 May; 125(5):907-11. PubMed ID: 3565366 [TBL] [Abstract][Full Text] [Related]
17. Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome. Kilbourne EM; Posada de la Paz M; Abaitua Borda I; Diez Ruiz-Navarro M; Philen RM; Falk H J Am Coll Cardiol; 1991 Sep; 18(3):711-7. PubMed ID: 1869734 [TBL] [Abstract][Full Text] [Related]
18. The toxic oil syndrome: a perspective on immunotoxicological mechanisms. Yoshida SH; German JB; Fletcher MP; Gershwin ME Regul Toxicol Pharmacol; 1994 Feb; 19(1):60-79. PubMed ID: 8159816 [TBL] [Abstract][Full Text] [Related]
19. The toxic oil syndrome: 20 years on. Diggle GE Int J Clin Pract; 2001; 55(6):371-5. PubMed ID: 11501225 [TBL] [Abstract][Full Text] [Related]
20. Toxicologists versus toxicological disasters: toxic oil syndrome, clinical aspects. Gómez de la Cámara A; Abaitua Borda I; Posada de la Paz M Arch Toxicol Suppl; 1997; 19():31-40. PubMed ID: 9079192 [No Abstract] [Full Text] [Related] [Next] [New Search]